Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
5.19
+0.59 (12.83%)
At close: Nov 26, 2025, 4:00 PM EST
5.12
-0.07 (-1.35%)
After-hours: Nov 26, 2025, 7:59 PM EST

Capricor Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-81.99-40.47-22.29-29.02-20.02-13.66
Upgrade
Depreciation & Amortization
1.761.431.070.530.250.14
Upgrade
Loss (Gain) From Sale of Assets
0.270.110.010.030.01-
Upgrade
Stock-Based Compensation
15.689.777.394.462.971.95
Upgrade
Other Operating Activities
0.33-0.05-0.020.16-0.27-
Upgrade
Change in Accounts Receivable
0.350-9.82-0.16-0.390.09
Upgrade
Change in Accounts Payable
5.481.941.331.210.991.83
Upgrade
Change in Unearned Revenue
-1.13-12.27-3.1827.45--
Upgrade
Change in Other Net Operating Assets
-1.79-0.46-0.080.25-0.34-0.41
Upgrade
Operating Cash Flow
-61.04-40-25.64.92-16.81-10.05
Upgrade
Capital Expenditures
-7.33-1.54-2.05-3.36-1.2-0.55
Upgrade
Investment in Securities
-61.66-114.647.16-31.71-5.99
Upgrade
Investing Cash Flow
-68.99-116.185.11-35.07-1.25.44
Upgrade
Long-Term Debt Issued
-----0.32
Upgrade
Net Debt Issued (Repaid)
-----0.32
Upgrade
Issuance of Common Stock
81.16152.7725.584.8720.2333.06
Upgrade
Financing Cash Flow
81.16152.7725.584.8720.2333.38
Upgrade
Net Cash Flow
-48.87-3.415.09-25.282.2228.77
Upgrade
Free Cash Flow
-68.38-41.53-27.641.56-18.01-10.6
Upgrade
Free Cash Flow Margin
-614.30%-186.50%-109.79%61.02%-7352.29%-3417.38%
Upgrade
Free Cash Flow Per Share
-1.51-1.18-1.030.06-0.78-0.68
Upgrade
Levered Free Cash Flow
-37.29-27.78-10.922.34-10.62-5.53
Upgrade
Unlevered Free Cash Flow
-37.29-27.78-10.922.34-10.62-5.53
Upgrade
Change in Working Capital
2.91-10.78-11.7528.750.261.51
Upgrade
Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q